Bladder Cancer

Overview

4.6 out of 5 (70 Reviews)

Credits

1.50

Post Assessment Questions

13

Start Date

1 Sep 2023

Last Review Date

15 Aug 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Bladder cancer, a prevalent malignancy affecting the urinary system, arises from the tissues of the bladder, a hollow organ responsible for storing urine. Urothelial carcinoma is the most frequent type, constituting over 90% of cases in industrialized nations. This type of cancer is notably common among older adults, with risk factors including smoking, chemical exposure, and chronic bladder inflammation. Presenting symptoms such as gross or microscopic hematuria, urinary frequency, and pelvic pain lead to its detection.

Early diagnosis and treatment are crucial for improving outcomes, as bladder cancer can range from noninvasive forms, which are confined to the inner layers of the bladder, to invasive types that penetrate deeper and can spread to other parts of the body. Treatment primarily involves transurethral resection and intravesical chemotherapy instillations but may also include laser ablation, Bacillus Calmette-Guerin bladder treatments, radiation therapy, chemotherapy, or surgical removal of part or all of the bladder.

This activity reviews the intricacies of bladder cancer, from its etiology to its therapeutic strategies. The latest advancements and comprehensive knowledge in diagnosing, treating, and managing this prevalent malignancy are discussed. Participants gain enhanced diagnostic acumen, learn evidence-based treatment protocols, and are updated on emerging research, fostering a deeper understanding of bladder cancer's evolving landscape and ultimately improving clinical practice.

The activity also highlights the interprofessional team's role in improving care for patients with this malignant condition. Collaborating with an interprofessional team enhances patient outcomes by integrating diverse expertise, ensuring comprehensive treatment plans, and providing holistic care that addresses all aspects of the patient's health, thereby improving the overall management and prognosis of bladder cancer.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Screen for symptoms and risk factors associated with bladder cancer in high-risk populations.

  • Assess the TNM and clinical staging used in the classification and evaluation of bladder cancer.

  • Apply the latest therapeutic guidelines in the treatment of both non-muscle-invasive and muscle-invasive bladder cancer.

  • Communicate the importance of collaboration among an interprofessional team to enhance the delivery of care for patients affected by bladder cancer.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physicians and Physician Associates: StatPearls, LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)TM. Physicians and PAs should only claim credit commensurate with the extent of their participation in the activity.

American Board of Anesthesiology: This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.

American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Pathology: Successful completion of this Continuing Certification activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Lifelong Learning (CME) credits in the American Board of Pathology’s Continuing Certification Program.

American Board of Surgery: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Royal College of Physicians and Surgeons of Canada: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Kristen Y. on 4/29/2021

Deborah Z. on 7/8/2021

ayodeji a. on 7/21/2021

Robert R. on 12/4/2021

on 12/29/2021

Timothy M. on 2/16/2022

Nancy B. on 6/26/2022

Deborah Z. on 7/6/2022

Elisabeth H. on 9/3/2022

Durwood N. on 10/22/2022

none

Marisol C. on 10/28/2022

These are excellent review topics which add to my knowledge base. Thank you!

Mathew M. on 12/7/2022

Wilbert W. on 12/18/2022

Renato P. on 1/3/2023

Josie P. on 1/8/2023

ANTONIO A. on 5/1/2023

ENJOYING THIS CME APPROACH

Naeem P. on 5/14/2023

Stephanie C. on 6/1/2023

Wendy S. on 7/9/2023

Jason B. on 8/19/2023

Connie D. on 8/29/2023

Khelsea C. on 8/29/2023

James M. on 9/18/2023

Samantha P. on 9/21/2023

Cher H. on 9/27/2023

Dennis R. on 10/8/2023

susanne r. on 12/7/2023

Michael B. on 11/8/2023

Esi C. on 12/4/2023

Bridget H. on 12/12/2023

Wassim E. on 12/17/2023

Raymond S. on 12/17/2023

Richard S. on 12/19/2023

Great review.

Richard P. on 12/24/2023

Cristovao V. on 12/26/2023

Bill N. on 12/29/2023

Dr K. on 1/11/2024

Michael F. on 1/22/2024

Edwin P. on 1/23/2024

zafar n. on 1/24/2024

Frank R. on 2/28/2024

Gurdeep C. on 2/28/2024

Redentor R. on 2/28/2024

douglas t. on 3/7/2024

Samantha P. on 4/8/2024

Mark A. on 4/8/2024

Lawrence S. on 4/25/2024

shahid m. on 4/27/2024

Richard F. on 4/30/2024

Justin K. on 5/13/2024

Jennifer R. on 5/14/2024

Jane B. on 5/28/2024

Narayan K. on 6/19/2024

Elaine B. on 6/15/2024

ishvar p. on 6/28/2024

Durathun F. on 7/2/2024

Ashley G. on 7/11/2024

Fariborz M. on 7/14/2024

Liz C. on 8/1/2024

Hung K. on 8/13/2024

Elizabeth S. on 8/22/2024

Jovelie D. on 8/25/2024

Rita N. on 9/17/2024

Sissi S. on 9/3/2024

Aqeel S. on 9/7/2024

My practice is hyperbaric medicine which was identified by Stat Pearls and a subset of modules was present of which this was one. This particular activity was strongly slanted to oncology practitioners and not very good for non-oncologists looking for a more generalized update. I also found many of the quiz questions were devoted to transitional cell carcinoma, a topic not discussed in the presentation focused on bladder cancer. My practice regularly includes patients radiated for bladder cancer with then delayed soft tissue cystitis and I was looking for more knowledge on how they were treated, followed up, and prognosticated.

James C. on 9/20/2024

Amelia H. on 9/26/2024

Jessica H. on 9/30/2024

Sarah D. on 10/4/2024

Jasmin K. on 10/8/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6649 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7894.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$73.50 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$329 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$499 per 1 year per user